These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1663439)

  • 1. Succimer, an oral lead chelator.
    Mann KV; Travers JD
    Clin Pharm; 1991 Dec; 10(12):914-22. PubMed ID: 1663439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity.
    Miller AL
    Altern Med Rev; 1998 Jun; 3(3):199-207. PubMed ID: 9630737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succimer: the first approved oral lead chelator.
    Jorgensen FM
    Am Fam Physician; 1993 Dec; 48(8):1496-502. PubMed ID: 8249780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
    Bradberry S; Sheehan T; Vale A
    QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
    Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
    J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chelation therapy to treat lead toxicity in children.
    Wegmann K
    Minn Med; 1992 Nov; 75(11):25-7. PubMed ID: 1331737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
    Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.
    Rogan WJ; Dietrich KN; Ware JH; Dockery DW; Salganik M; Radcliffe J; Jones RL; Ragan NB; Chisolm JJ; Rhoads GG;
    N Engl J Med; 2001 May; 344(19):1421-6. PubMed ID: 11346806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB; Anderson RL; Super DM
    Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of elevated blood lead levels and succimer chelation therapy on physical growth in developing rhesus monkeys.
    Lasky RE; Laughlin NK; Luck ML
    Environ Res; 2001 Sep; 87(1):21-30. PubMed ID: 11534961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ; Pande M; Kannan GM; Mehta A
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of succimer on the absorption of lead in adults determined by using the stable isotope 204Pb.
    Smith DR; Markowitz ME; Crick J; Rosen JF; Flegal AR
    Environ Res; 1994 Oct; 67(1):39-53. PubMed ID: 7925193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chelation therapy in intoxications with mercury, lead and copper.
    Cao Y; Skaug MA; Andersen O; Aaseth J
    J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic and lead induced free radical generation and their reversibility following chelation.
    Flora SJ; Flora G; Saxena G; Mishra M
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.
    Glotzer DE
    Drug Saf; 1993 Aug; 9(2):85-92. PubMed ID: 8397892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
    van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
    Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.